Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 20

Results For "IMI"

5314 News Found

Haisco licenses two drug candidates to Nuvectis in potential $1.4 billion deal
News | June 25, 2026

Haisco licenses two drug candidates to Nuvectis in potential $1.4 billion deal

Nuvectis gains global rights outside select Asian markets for oncology and complement disease therapies, with Haisco eligible for milestone payments and royalties


AI moves from experimentation to enterprise tool across pharma value chain: GlobalData
Digitisation | June 25, 2026

AI moves from experimentation to enterprise tool across pharma value chain: GlobalData

34% of pharma firms have already deployed function-specific AI, with drug discovery, clinical trials, and medical writing emerging as key high-impact use cases


Shilpa Medicare subsidiary settles Rs. 20.13 crore dispute with Sartorius for Rs. 9 crore
News | June 25, 2026

Shilpa Medicare subsidiary settles Rs. 20.13 crore dispute with Sartorius for Rs. 9 crore

The resolution significantly reduces a long-standing contingent liability from the company's books


Teva study shows Huntington’s disease treatment improves life for patients & caregivers
Clinical Trials | June 24, 2026

Teva study shows Huntington’s disease treatment improves life for patients & caregivers

The findings come from the first and only decentralized real-world study examining how HD chorea affects patients and caregivers and how treatment impacts quality of life


Oval & Merck Specialities sign strategic pact to expand access to advanced IVF care in India
News | June 24, 2026

Oval & Merck Specialities sign strategic pact to expand access to advanced IVF care in India

The collaboration comes at a time when access to high-quality fertility treatment remains uneven, despite rapid market expansion


European Commission approves AbbVie's MAVIRET for acute Hepatitis C treatment
Drug Approval | June 24, 2026

European Commission approves AbbVie's MAVIRET for acute Hepatitis C treatment

Approval makes it the first and only therapy in the EU indicated for both acute and chronic hepatitis C, supported by Phase 3 data


Biocon to supply insulin under Malaysia MoH contracts worth over Rs. 515 crore
Biopharma | June 24, 2026

Biocon to supply insulin under Malaysia MoH contracts worth over Rs. 515 crore

Partnership with Duopharma Biotech covers human insulin, insulin glargine and insulin aspart, supporting diabetes care and medicine security in Malaysia


SwishX selected for Anthropic-AWS Agentic AI Accelerator 2026
Digitisation | June 24, 2026

SwishX selected for Anthropic-AWS Agentic AI Accelerator 2026

Bengaluru-based startup recognised for building autonomous AI agents for pharmaceutical and medtech commercial operations, joins select cohort of 40 startups in India-focused accelerator programme


CARE Hospitals completes 500 robotic knee replacement surgeries in one year
Hospitals | June 24, 2026

CARE Hospitals completes 500 robotic knee replacement surgeries in one year

Visakhapatnam-based hospital reaches major milestone in robotic orthopaedics, helping patients across North Andhra Pradesh and Odisha regain mobility through precision-assisted knee replacement procedures.


AbbVie unveils 9-Yr CLL data showing lasting survival benefit for Venetoclax-based therapy
Biopharma | June 23, 2026

AbbVie unveils 9-Yr CLL data showing lasting survival benefit for Venetoclax-based therapy

Researchers emphasized that the benefit persisted well beyond the treatment period, reinforcing the clinical rationale for time-limited therapy in selected patients